Related Experiment Video
Updated: May 6, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
14.4K
Stroke subtypes and interventional studies for transient ischemic attack
Philippe Lavallée1, Pierre Amarenco
1INSERM U-698, Department of Neurology and Stroke Center, AP-HP, Bichat-Claude Bernard Hospital, University Paris Diderot, Sorbonne Paris Cité, Paris, France.
Frontiers of Neurology and Neuroscience
|October 26, 2013
Summary
Transient ischemic attack (TIA) is a critical stroke risk. Early antithrombotic treatment is vital, with combination therapy showing promise, while aggressive risk factor management is key for long-term stroke prevention.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Transient ischemic attack (TIA) is the primary risk factor for ischemic stroke.
- Immediate emergency treatment is crucial due to the high risk in the initial hours post-symptom onset.
Purpose of the Study:
- To review current and emerging treatment strategies for acute TIA and long-term stroke prevention.
- To highlight the importance of tailored therapies based on stroke etiology and patient factors.
Main Methods:
- Review of recent data and meta-analyses on antithrombotic therapies.
- Analysis of guidelines and trial data for stroke prevention strategies.
- Evaluation of novel anticoagulants and interventional procedures.
Main Results:
- Combination antiplatelet therapy (clopidogrel and aspirin) is increasingly supported over monotherapy for acute TIA.
- Anticoagulants are the preferred treatment for cardioembolic stroke, with new oral agents offering improved safety.
- Aggressive management of vascular risk factors (hypertension, hyperlipidemia, diabetes, smoking) is essential for preventing recurrent events.
Conclusions:
- Current guidelines recommend antiplatelet monotherapy, but combination therapy is gaining traction.
- New oral anticoagulants are effective and safer for atrial fibrillation-related stroke prevention.
- Comprehensive management of vascular risk factors is paramount in TIA and stroke prevention.
Related Concept Videos
01:26Transient Ischemic Attack l: Introduction
35
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
35
01:29Stroke: Introduction and Types
75
A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
75
01:15Ischemic Stroke l: Introduction
57
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
57
01:15Ischemic Stroke ll: Pathophysiology
74
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
74
01:30Acute Coronary Syndrome III: Diagnostic Studies
502
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
01:30Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K